A detailed history of Sherbrooke Park Advisers LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 24,469 shares of ADPT stock, worth $186,453. This represents 0.05% of its overall portfolio holdings.

Number of Shares
24,469
Holding current value
$186,453
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.37 - $6.78 $106,929 - $165,899
24,469 New
24,469 $147 Million
Q1 2024

May 15, 2024

BUY
$2.88 - $4.8 $126,313 - $210,523
43,859 New
43,859 $141 Million
Q2 2023

Aug 14, 2023

BUY
$6.19 - $8.78 $89,166 - $126,475
14,405 New
14,405 $96.7 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.09B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.